5 completed, 1 active not recruiting, 1 not yet recruiting, 1 withdrawn. 5 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Withdrawn 1 |
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Shanghai HEP Pharmaceutical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D Hepalatide 2.1mg, Placebo of Hepalatide - Hepatitis D, Chronic | Phase 3 | Not yet recruiting | Shanghai HEP Pharmaceutical Co., Ltd. | 150 | 2026-04-01 | 2025-12-30 |
| A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin hepalatide - Type 2 Diabetes Patients | Phase 1 / Phase 2 | Withdrawn | Shanghai HEP Pharmaceutical Co., Ltd. | 2025-12-01 | 2023-12-08 | |
| A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D hepalatide - Hepatitis D | Phase 2 | Active not recruiting | Shanghai HEP Pharmaceutical Co., Ltd. | 90 | 2024-12-11 | 2025-12-23 |
| Study of Hepalatide in Chronic Hepatitis D(CHD) Patients Hepalatide, Hepalatide Placebo - Chronic Hepatitis D Infection | Phase 2 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 23 | 2023-10-07 | 2024-04-24 |
| A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets - Chronic Hepatitis B | Phase 2 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 8 | 2022-08-23 | 2024-07-15 |
| A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B Hepalatide 2.1mg, Hepalatide 4.2mg, Hepalatide 6.3mg - Hepatitis B, Chronic | Phase 2 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 96 | 2021-06-18 | 2025-01-27 |
| Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers Hepalatide, Placebo - Hepatitis B， Chronic | Phase 1 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 35 | 2016-08-01 | 2017-01-23 |
| Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers Hepalatide, Placebo - Hepatitis B， Chronic | Phase 1 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 48 | 2015-10-01 | 2017-02-14 |
Hepatitis B, Chronic (4) · Hepatitis D, Chronic (2) · Hepatitis D (1)
Drug and Narcotic Control (2) · peginterferon alfa-2a (2) · tenofovir alafenamide (1)
China (6) · Mongolia (2)
Fusheng Wang (1) · Junqi Niu (1) · Junqi Niu, Professor (1) · Oyunbileg Janchiv (1) · Qin Zhang (1) · Yanhang Gao (1)